Insulet | PODD - Trade Debtors


Insulet reported $588.7M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Align Technology USD 1.15B 23.28M Jun/2026
AtriCure USD 79.98M 8.67M Jun/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.36B 159M Jun/2026
Boston Scientific USD 3.03B 101M Mar/2026
Cardinal Health USD 13.82B 167M Jun/2026
Cooper Companies USD 788.9M 20.3M Jun/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Globus Medical USD 739.28M 3.84M Jun/2026
ICU Medical USD 183.53M 43.29M Jun/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 588.7M 44M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.36B 286M Jun/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Solventum Corp USD 1.69B 346M Jun/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 162.06M 21.39M Jun/2026
Teleflex USD 364.61M 917K Jun/2026
West Pharmaceutical Services USD 712M 26.4M Jun/2026
Zimmer Biomet Holdings USD 1.77B 40.9M Jun/2026